MIT Scientists Reprogram Immune Cells to Combat Cancer and Liver Damage In Vivo

Scientists at MIT have developed nanoparticles capable of reprogramming immune cells directly within the body to target and destroy cancer cells and harmful immune cells. In mouse experiments, this breakthrough successfully eliminated tumors and reversed liver damage, offering a simpler and more cost-effective approach to powerful immune therapies for cancer and autoimmune diseases.